Navigation Links
$6.75 million awarded to Case Western Reserve to study IBD
Date:12/20/2011

Investigators at Case Western Reserve University School of Medicine received a $6.75 million Program Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the role of innate immunity in inflammatory bowel disease (IBD). For years, scientists have focused their attention on the role of lymphocytes and the adaptive immune system in the cause of Crohn's disease, a chronic debilitating disease affecting more than one million individuals in the United States. This grant supports the investigation of a new pathogenesis, or cause of the disease, which was discovered by Fabio Cominelli, MD, PhD, professor of medicine and pathology, chief of the division of gastrointestinal and liver disease at Case Western Reserve University School of Medicine and director of the Digestive Health Institute at University Hospitals Case Medical Center.

Dr. Cominelli and a team of investigators in the Digestive Health Research Center, using a spontaneous mouse model of ileitis, a type of Crohn's disease, discovered that the intestinal innate immune system may play a primary and critical role in causing the disease. The body's innate immune system represents the first line of general defense against harmful agents and includes infection-fighting cells. In the ileitis model, they found a deficit of these cells and as a result, harmful agents weren't being eliminated from the body. Previously, the scientific medical community thought there was a specific component triggering a reaction within the body, much like production of an antibody in response to a particular virus but rather it is a deficit in the body's natural immune system.

"We are very excited about this opportunity to study this unique mouse model of IBD and make important discoveries that can be directly applied to improve patient care and developing novel therapeutic modalities for this devastating disease. We are honored that this is the first new Program Project Grant funded by the National Institute of Diabetes and Digestive and Kidney Diseases since 2006 to study IBD," commented Dr. Cominelli, who also hold the Hermann Menges, Jr. Chair in Internal Medicine.

The team is working to develop a novel therapeutic drug target in order to manipulate the immune system. Based on the data, they hope to begin to develop a cure for Crohn's disease in five to 10 years.

The team directed by Dr. Cominelli is comprised of Derek Abbott, MD, assistant professor of pathology and Dr. Theresa Pizarro, PhD, associate professor of pathology, both at Case Western Reserve University School of Medicine, and Dr. Klaus Ley, head of the Inflammation Division at the La Jolla Institute of Allergy & Immunology in San Diego.


'/>"/>
Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. Wolfson Foundation awards £20 million to UCL for experimental neurology center
2. NYU study concludes that dentists could screen 20 million Americans for chronic physical illnesses
3. Emory and US CDC partner to continue building global public health network with $6 million grant
4. Wistar receives $4.7 million to develop drug against Epstein-Barr virus-related cancers
5. Millions of Americans Are Victims of Sexual Violence: CDC
6. Northwestern receives $10 million gift for life sciences graduates
7. RI Hospital receives $1.5 million grant to study treatments for body dysmorphic disorder
8. 2 million Californians report mental health needs; most receive little or no treatment
9. Saving millions of lives and protecting our climate through clean cooking options
10. $3.8 million grant investigates link between sleep apnea and atrial fibrillation
11. Wayne State receives $1.9 million from NIH to create novel cystic fibrosis treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: